Immunoassays

AMA-M2-M is a solid phase enzyme immunoassay employing native mitochondial M2 antigen for the quantitative detection of IgM antibodies against M2 in human serum. The assay is a tool in the diagnosis of the primary biliary cirrhosis (PBC).

AMA-M2-Check is a solid phase enzyme immunoassay employing native mitochondial M2 antigen for the quantitative detection of IgG and IgM antibodies against M2 in human serum. The assay is a tool in the diagnosis of the primary biliary cirrhosis (PBC).

beta2-Microglobulin is a solid phase enzyme immunoassay employing highly purified antihuman-beta-2-Microglobulin antibodies for the quantitative detection of beta-2-Microglobulin in human serum, plasma and urine.

Borrelia-G is a solid phase enzyme immunoassay for the quantitative detection of IgG antibodies against Borrelia burgdorferi. The assay is a tool in the diagnosis of Lyme borreliosis.

Borrelia-M is a solid phase enzyme immunoassay for the quantitative detection of IgM antibodies against Borrelia burgdorferi. The assay is a tool in the diagnosis of Lyme borreliosis.

Protein C is a solid phase enzyme immunoassay for the quantitative determination of Protein C in citrated human plasma. The determination of Protein C aids in the risk estimation of thrombosis.

Protein S is a solid phase enzyme immunoassay for the quantitative determination of Total and Free Protein S in citrated human plasma. The determination of Total and Free Protein S aids in the risk estimation of thrombosis.

The picoAMH ELISA is an enzyme-linked immunosorbent assay (ELISA) for the quantitative measurement of anti-Müllerian hormone (AMH), also known as Müllerian Inhibiting Substance (MIS), concentrations in human serum, Li-Heparin and K2 EDTA plasma.

The PAPP-A enzyme linked immunosorbent assay (ELISA) kit provides materials for the quantitative measurement of PAPP-A in serum and other biological fluids. This assay is intended for in vitro diagnostic use.

Cardiolipin-Check is a solid phase enzyme immunoassay employing highly purified cardiolipin plus native human ß2-glycoprotein I for the combined quantitative detection of IgA, IgG and IgM antibodies against cardiolipin in human serum.